Edwards Lifesciences Corporation (ETR:EWL)

Edwards Lifesciences Revenue

Edwards Lifesciences had revenue of $1.55B USD in the quarter ending September 30, 2025, with 14.67% growth. This brings the company's revenue in the last twelve months to $5.88B, up 10.60% year-over-year. In the year 2024, Edwards Lifesciences had annual revenue of $5.44B with 8.57% growth.

• Revenue (ttm): $5.88B
• Revenue Growth: +10.60%
• P/S Ratio: 8.65
• Revenue / Employee: $372.39K
• Employees: 15,800
• Market Cap: 43.37B EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	5.44B	429.50M	8.57%
Dec 31, 2023	5.01B	546.00M	12.23%
Dec 31, 2022	4.46B	-768.50M	-14.69%
Dec 31, 2021	5.23B	846.20M	19.29%
Dec 31, 2020	4.39B	38.30M	0.88%
Dec 31, 2019	4.35B	625.20M	16.79%
Dec 31, 2018	3.72B	287.50M	8.37%
Dec 31, 2017	3.44B	471.60M	15.91%
Dec 31, 2016	2.96B	470.00M	18.85%
Dec 31, 2015	2.49B	170.80M	7.35%
Dec 31, 2014	2.32B	277.40M	13.56%
Dec 31, 2013	2.05B	145.90M	7.68%
Dec 31, 2012	1.90B	221.00M	13.17%
Dec 31, 2011	1.68B	231.60M	16.01%
Dec 31, 2010	1.45B	125.60M	9.51%
Dec 31, 2009	1.32B	83.70M	6.76%
Dec 31, 2008	1.24B	146.60M	13.44%
Dec 31, 2007	1.09B	54.10M	5.22%
Dec 31, 2006	1.04B	39.10M	3.92%
Dec 31, 2005	997.90M	-	-